Edition 356
28/02/2023
Subjects- ‘Fundamentally Dishonest’ NFCI Claimant to Face Committal Proceedings for Civil Contempt
- £1.5 Million Military Deafness Claim Reaches Trial: Barry v The Secretary of State for Defence Ministry of Defence (QB-2020-003077)
- What Happens if the Damages Claims Pilot is Used Inappropriately?
- Slater and Gordon Rues Disastrous Acquisition of Quindell’s Professional Services Division, as Lawsuit Surrounding Sale Terms is Heard 8-Years Later
- Only Seeing the ‘Tip of the Iceberg’ with Breast Implant Associated Cancer Claims, Product Liability Lawyer Avers
- Parliamentary Group Implores Cape’s Parent Company to Donate £10 Million to ‘Recompense Victims of Asbestos Disease’, Following Non-Party Disclosure Case
- New Form for Claims Made Under the Pneumoconiosis etc (Workers’ Compensation) Act 1979 and the 2008 Diffuse Mesothelioma Scheme – What Has Changed?
- European Commission Recommends New Binding Occupational Exposure Limits for Lead and Diisocyanates
- ICLR Study Finds ‘Significant’ Shortage of Published Court Judgments, as the Government’s Call for Evidence on the Theme of Open Justice Looms
- The Ebb and Flow of the Personal Injury Claims Market – What Can We Learn from the Latest Financial Statements Filed by Claimant Law Firms?
Edition 355
23/01/2023
Subjects- Sewing Machine Vibrations Disturbed Asbestos, Coroner Finds in ‘Industrial Disease’ Ruling at Inquest
- Firm Specialising in Cancer Claims Relating to Talc Exposure Launches in UK
- NAHL Doubles TV Marketing Budget to Grow Personal Injury Market
- MoJ Initiates Call for Evidence on Multiple Personal Injury Discount Rates
Edition 354
09/01/2023
Subjects- Mobile Phone Radiation-Induced Brain Cancer – an ‘Occupational Disease’: MN v INAIL (2022)
- £30,000 Wasted Costs Order Secured for Another of Asons’ Fraudulent Whiplash Claims
- Industry Commentators Describe the Civil Justice System, in England and Wales, as a ‘Cinderella Service’, Following Publication of Q3 2022 Statistics
- Extending Fixed Recoverable Costs – Long-Anticipated Reforms Delayed Until October 2023
- Emerging Product Litigation Issue – US FDA Review Highlights Risk of Multiple Cancer Sub-Types for Women with Breast Implants?